LakeShore Biopharma Co., Ltd (LSB) — Cash Flow Quality Index

Latest as of June 2022: -0.06x

LakeShore Biopharma Co., Ltd (LSB) has a Cash Flow Quality Index of -0.06x as of June 2022. Operating cash flow of $-693.96K is below net income of $11.52 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore LakeShore Biopharma Co., Ltd assets under control for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.06x

Operating CF / Net Income

Operating Cash Flow

$-693.96K

USD

Net Income

$11.52 Million

USD

Data as of

Jun 2022

Most recent filing

Annual Cash Flow Quality Index for LakeShore Biopharma Co., Ltd (None–None)

Year-by-year earnings quality comparison for LakeShore Biopharma Co., Ltd. For live market cap and the full company financial profile, see LakeShore Biopharma Co., Ltd stock valuation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.